Related Experiment Videos
Treatment of pediatric hypertension
1Colleges of Pharmacy, The Ohio State University, Columbus 43210, USA.
Insights
Pediatric hypertension affects 1-3% of children. Treatment options range from nonpharmacologic approaches for mild cases to various drug classes and intravenous medications for emergencies.
Area of Science:
- Pediatric Nephrology
- Cardiology
- Clinical Pharmacology
Background:
- Hypertension prevalence in the pediatric population is estimated at 1-3%.
- Effective management strategies for pediatric hypertension are crucial for long-term health outcomes.
- Identifying and reviewing clinical trials is essential for evidence-based treatment guidelines.
Purpose of the Study:
- To systematically review clinical trials on the treatment of pediatric hypertension.
- To identify effective pharmacologic and non-pharmacologic treatment options for children with hypertension.
- To summarize current therapeutic approaches for both chronic and emergency pediatric hypertension.
Main Methods:
- Conducted a MEDLINE search from January 1966 to March 1999.
- Prioritized randomized studies, but included nonrandomized studies and case reports when necessary.
- Utilized review articles to identify relevant references for comprehensive data collection.
Main Results:
- Nonpharmacologic treatments can be effective for mild to moderate pediatric hypertension or as adjunctive therapy.
- Common drug classes for chronic pediatric hypertension include calcium channel blockers, ACE inhibitors, diuretics, and beta-blockers.
- Intravenous labetalol, nicardipine, and nitroprusside are effective for hypertensive emergencies in children.
Conclusions:
- Treatment of pediatric hypertension requires individualized approaches based on patient and drug characteristics.
- A range of therapeutic options exists, from lifestyle modifications to potent antihypertensive medications.
- Further research and ongoing review of clinical trials are vital for optimizing pediatric hypertension management.
Abstract:
We conducted a MEDLINE search from January 1966-March 1999 to obtain information on clinical trials of treatment of pediatric hypertension. An article was selected for review if it described a randomized or nonrandomized study; randomized studies were given priority. Case reports were considered when studies were unavailable. Review articles were useful in identifying references. According to data we collected, hypertension is present in 1-3% of the pediatric population. Nonpharmacologic treatment may be effective initially in those with mild to moderate disease or as an adjunct to drug therapy. Drugs for treatment of chronic hypertension include calcium channel blockers, angiotensin-converting enzyme inhibitors, diuretics, and beta-blockers. Patient and drug characteristics determine therapy. Intravenous labetalol, nicardipine, and nitroprusside are effective for treating hypertensive emergencies.